{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-10-27T12:23:55.753178+00:00",
  "news": [
    {
      "title": "Ashton Thomas Private Wealth LLC Has $25.72 Million Holdings in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOOTd0eHE1WGdJaEFLcG1ldE1qMGdBcVVqRDFaSEFIMFpTV1NvNGNicmlyNGEyM2pjaXhBbHlONk5ITUR0Yk5MV0ZNdW1CcXBIQndNRnQ2Z2MxYWEtbHI0dVVjdUl3RzMtUElMaWlRWlhURm1WcVhoTjhidzItZGJXWl9QSV9UME44aE41UVVRZzhzeFdSZEtVSG9JV2ZwdV85b2JibHlxRHUzdGNGTGQ0VlRHMGVwUGhzU3ZkWTFpcHpURGZZN29ibm4tNmZoSW5kNkdJ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOOTd0eHE1WGdJaEFLcG1ldE1qMGdBcVVqRDFaSEFIMFpTV1NvNGNicmlyNGEyM2pjaXhBbHlONk5ITUR0Yk5MV0ZNdW1CcXBIQndNRnQ2Z2MxYWEtbHI0dVVjdUl3RzMtUElMaWlRWlhURm1WcVhoTjhidzItZGJXWl9QSV9UME44aE41UVVRZzhzeFdSZEtVSG9JV2ZwdV85b2JibHlxRHUzdGNGTGQ0VlRHMGVwUGhzU3ZkWTFpcHpURGZZN29ibm4tNmZoSW5kNkdJ?oc=5\" target=\"_blank\">Ashton Thomas Private Wealth LLC Has $25.72 Million Holdings in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-10-27T10:06:54+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5\" target=\"_blank\">Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The New York Times</font>",
      "published": "2025-10-23T09:00:45+00:00",
      "source": "The New York Times"
    },
    {
      "title": "ESMO 2025 – bemarituzumab fails to convince | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPME91bWdtOGVBLW54MmFCaWJ5UEcxaDFycnZuZXJBMlhUUXZyUndFckw0OTR1VjhHajV1VHlWSlJaX3l3bWRTUS1PbGwtVjR3V0ZoaXRUYXMxV3dZbUdUa1E1TDhMWWRCRmcwNnlKVlpVRm9rYmRQNy1SY2hSa1diaThJXzVfS1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxPME91bWdtOGVBLW54MmFCaWJ5UEcxaDFycnZuZXJBMlhUUXZyUndFckw0OTR1VjhHajV1VHlWSlJaX3l3bWRTUS1PbGwtVjR3V0ZoaXRUYXMxV3dZbUdUa1E1TDhMWWRCRmcwNnlKVlpVRm9rYmRQNy1SY2hSa1diaThJXzVfS1E?oc=5\" target=\"_blank\">ESMO 2025 – bemarituzumab fails to convince | ApexOnco - Clinical Trials news and analysis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Oncology Pipeline</font>",
      "published": "2025-10-21T13:50:35+00:00",
      "source": "Oncology Pipeline"
    },
    {
      "title": "With questions surrounding its gastric cancer drug, Amgen fills in some gaps - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1zNDBYYlJHWGU3TktJb1dpeUI0MkUxZFBpQklTbW1YT3BWWGw4RjVNSm5BOFBZTUJDamRmNUg3bVJaOHhqV21QZXF0MzdBOU14V1JVZVhseWNaSTI4M2NGa0xkbUJLVHhvel9SWDhYd251Y3l3aFAzZkZndw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMie0FVX3lxTE1zNDBYYlJHWGU3TktJb1dpeUI0MkUxZFBpQklTbW1YT3BWWGw4RjVNSm5BOFBZTUJDamRmNUg3bVJaOHhqV21QZXF0MzdBOU14V1JVZVhseWNaSTI4M2NGa0xkbUJLVHhvel9SWDhYd251Y3l3aFAzZkZndw?oc=5\" target=\"_blank\">With questions surrounding its gastric cancer drug, Amgen fills in some gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-10-20T14:52:07+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Top Research Reports for Amazon.com, Wells Fargo & Amgen - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPbndFZmNreDltZTBwNE5HRHFmWmFDQXJTVzZNQTZ1OXIwOG5sUDRXVlRGWS1Vd2VQRzZ3QlAycHVrcVhsWXd3UGItMlRRZ0RlcFhjdzFTaWJpdTF0bjQ1NF9kdENEUm1IUVNLTjRodkFxd2RJR1BsWm5CeXdES2JEeFkyaw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPbndFZmNreDltZTBwNE5HRHFmWmFDQXJTVzZNQTZ1OXIwOG5sUDRXVlRGWS1Vd2VQRzZ3QlAycHVrcVhsWXd3UGItMlRRZ0RlcFhjdzFTaWJpdTF0bjQ1NF9kdENEUm1IUVNLTjRodkFxd2RJR1BsWm5CeXdES2JEeFkyaw?oc=5\" target=\"_blank\">Top Research Reports for Amazon.com, Wells Fargo & Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-23T20:41:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQaXdzbXE0cjkzTHVJWHJtenlXSDlybk42SDJCWnkzYVM0MzdlQlJiVGRkUUQtNkUtcHBxTVlqamVtazJ3WnhyZWlReUdXMDdIZ0FHemxuek5MZmdoWG52Z0l3OGszU2RjMGJsODJJbURPTEswYklJUXY4dFRaR2VvcnNvNGVORExLRE41UmhwRmwwdlRzUzM2YmpxRFhXM1JvU0hZM3NSakdza2Q1dmFMQWh1WXdoOVdqak9iZklDdE10d21FVC1GdjBOX1Y1clI3V1lqd1RKdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQaXdzbXE0cjkzTHVJWHJtenlXSDlybk42SDJCWnkzYVM0MzdlQlJiVGRkUUQtNkUtcHBxTVlqamVtazJ3WnhyZWlReUdXMDdIZ0FHemxuek5MZmdoWG52Z0l3OGszU2RjMGJsODJJbURPTEswYklJUXY4dFRaR2VvcnNvNGVORExLRE41UmhwRmwwdlRzUzM2YmpxRFhXM1JvU0hZM3NSakdza2Q1dmFMQWh1WXdoOVdqak9iZklDdE10d21FVC1GdjBOX1Y1clI3V1lqd1RKdw?oc=5\" target=\"_blank\">AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers - CNBC",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPWkRpS1ROdl9hMEp5dl9hTm9HaEJBR1NEdFJXNmpVbHNjaUUyeExYdDRodVJkREl5Q3ItdWM1aTQyby1tb0VrQjIxUmpFMEx3Z3RoaTkwTkNIcTQ1QU5LVXNHbmtfYWQyWjZ2VEFpNlBYdmJsVk16R0tDY3lKR2lmTl94V0NBVGF4ejdzZ2ZPbVdDVzNWaldyMXhoY9IBoAFBVV95cUxQUnozRC1oUHNMRUt5NnRpUl9xLXplTC10bjVpYmJucHd4WGRUZEVSRUQ0UG5BZnEteWNjNEVJR3R5VnpHRUJycVZGamZFV2wtNnM2UTFKSGt3dk5ROGNpeklQN2U4LTBYNUVyYl9SZzZTSFcyMWluaFdHZWszRjJiYzZqOUVSbWVxNTRRLU5lay1uNmJPNU1BSXZ0dDJzVEhI?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPWkRpS1ROdl9hMEp5dl9hTm9HaEJBR1NEdFJXNmpVbHNjaUUyeExYdDRodVJkREl5Q3ItdWM1aTQyby1tb0VrQjIxUmpFMEx3Z3RoaTkwTkNIcTQ1QU5LVXNHbmtfYWQyWjZ2VEFpNlBYdmJsVk16R0tDY3lKR2lmTl94V0NBVGF4ejdzZ2ZPbVdDVzNWaldyMXhoY9IBoAFBVV95cUxQUnozRC1oUHNMRUt5NnRpUl9xLXplTC10bjVpYmJucHd4WGRUZEVSRUQ0UG5BZnEteWNjNEVJR3R5VnpHRUJycVZGamZFV2wtNnM2UTFKSGt3dk5ROGNpeklQN2U4LTBYNUVyYl9SZzZTSFcyMWluaFdHZWszRjJiYzZqOUVSbWVxNTRRLU5lay1uNmJPNU1BSXZ0dDJzVEhI?oc=5\" target=\"_blank\">Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-10-07T07:00:00+00:00",
      "source": "CNBC"
    },
    {
      "title": "Amgen to sell cholesterol drug at 60% discount to cash-paying US patients - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQY093WGV4Y3o1SmQ5TElWbXNtbUxhYUgyLTNNXzdnTUM4dEphOVZ1ZkNieUNlbGx0SmtNbzRpaWVRY1VnVFpld2RVMU5Xc0E1WjJ6RlVCeDkwQ25kOVlMekI5MGlNaW5UZUN0dVdKWWFfQ0ExMjJIUEIwakxQckd1eFc4YzROWUxwZ1h6T0RsdXFGTXNIQTdXSk1FWUwxOVZkTkdmdW53TlRZdGZMRDE1eHB1MVNoZzMzUExrQ1UxRTJGRGw1dF84V200VQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiywFBVV95cUxQY093WGV4Y3o1SmQ5TElWbXNtbUxhYUgyLTNNXzdnTUM4dEphOVZ1ZkNieUNlbGx0SmtNbzRpaWVRY1VnVFpld2RVMU5Xc0E1WjJ6RlVCeDkwQ25kOVlMekI5MGlNaW5UZUN0dVdKWWFfQ0ExMjJIUEIwakxQckd1eFc4YzROWUxwZ1h6T0RsdXFGTXNIQTdXSk1FWUwxOVZkTkdmdW53TlRZdGZMRDE1eHB1MVNoZzMzUExrQ1UxRTJGRGw1dF84V200VQ?oc=5\" target=\"_blank\">Amgen to sell cholesterol drug at 60% discount to cash-paying US patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "product_launches": [
    {
      "title": "Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients - MyChesCo",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5\" target=\"_blank\">Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MyChesCo</font>",
      "published": "2025-10-27T04:00:00+00:00",
      "source": "MyChesCo"
    },
    {
      "title": "Forecast Cut: Will Amgen Inc. (AMG0) stock deliver stable dividends - Product Launch & Low Risk Entry Point Tips - nchmf.gov.vn",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQbEg2SXdxLU80YmdHQnVEQ0VMYl9hYlRieVJmVEpSbWFUYkpKMl9BQy1ISE14S29RT095dVlvaUlJVzdqVHVpdG5MVG5UdS1iTTFYemluX3FxNTh1OFk2Z3NjVjZfa3BCX29MQUN6UGR3NTZfMGNjWEZLX21jN3NNbGI5NGRDRXpLZW40RENsZVgyUjg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxQbEg2SXdxLU80YmdHQnVEQ0VMYl9hYlRieVJmVEpSbWFUYkpKMl9BQy1ISE14S29RT095dVlvaUlJVzdqVHVpdG5MVG5UdS1iTTFYemluX3FxNTh1OFk2Z3NjVjZfa3BCX29MQUN6UGR3NTZfMGNjWEZLX21jN3NNbGI5NGRDRXpLZW40RENsZVgyUjg?oc=5\" target=\"_blank\">Forecast Cut: Will Amgen Inc. (AMG0) stock deliver stable dividends - Product Launch & Low Risk Entry Point Tips</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">nchmf.gov.vn</font>",
      "published": "2025-10-18T06:18:36+00:00",
      "source": "nchmf.gov.vn"
    },
    {
      "title": "$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S. - Stock Titan",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5\" target=\"_blank\">$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Stock Titan"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-24",
      "close": 291.760009765625
    },
    "history": [
      {
        "date": "2025-10-16",
        "close": 295.80999755859375
      },
      {
        "date": "2025-10-17",
        "close": 298.80999755859375
      },
      {
        "date": "2025-10-20",
        "close": 303.3299865722656
      },
      {
        "date": "2025-10-21",
        "close": 301.1400146484375
      },
      {
        "date": "2025-10-22",
        "close": 295.9800109863281
      },
      {
        "date": "2025-10-23",
        "close": 292.8900146484375
      },
      {
        "date": "2025-10-24",
        "close": 291.760009765625
      }
    ],
    "name": "Amgen Inc."
  }
}